CU50 + KPV10 + BPC10

CU50, KPV10, and BPC10 form a research peptide combination with complementary antimicrobial, anti-inflammatory, and tissue-repair properties. 

• CU50 is understood to refer to GHK-Cu 50mg, a copper-binding peptide complex studied for its role in collagen regulation, dermal fibroblast activity, skin-repair models, wound-healing research, and extracellular matrix remodelling.
• KPV10 refers to KPV, the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH). KPV is studied for anti-inflammatory activity, including effects on NF-κB signalling, cytokine-related pathways, and epithelial or immune-cell models.
• BPC10 appears to refer to a BPC-related peptide component, although its exact identity should be confirmed from the client’s formula sheet. If associated with BPC-157, it should be described cautiously as a BPC-related research peptide studied in relation to tissue-repair, angiogenesis-related, nitric-oxide-related, and gastrointestinal models, primarily in preclinical research.

Together, these peptides work proposedly and experimentally to control infection, reduce inflammation, stimulate angiogenesis, and accelerate tissue healing through multiple complementary biological pathways in preclinical models, with limited confirmed human clinical evidence.